Skip to main content
. 2019 Jan 29;92(5):e418–e428. doi: 10.1212/WNL.0000000000006850

Figure 1. Decision trees for the comparison of individual tests (A) and of testing strategies (B).

Figure 1

(A) A patient with epilepsy of unknown etiology and no features suggestive of any particular genetic etiology can choose 4 individual tests: no genetic testing, CMA, EP, and WES. (B) A patient with epilepsy of unknown etiology and no features suggestive of any particular genetic etiology can choose 7 testing strategies: no genetic testing, CMA ± EP ± WES, CMA ± WES ± EP, EP ± CMA ± WES, EP ± WES ± CMA, WES ± CMA ± EP, and WES ± EP ± CMA. CMA = chromosomal microarray; EP = epilepsy panel; WES = whole-exome sequencing.